Gene · 4300
Papers2,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms underlying linear ubiquitination and implications in tumorigenesis and drug discovery. | Cell Commun Signal | 2023 | 38017534 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| A Review of Childhood Acute Myeloid Leukemia: Diagnosis and Novel Treatment. | Pharmaceuticals (Basel) | 2023 | 38004478 | PubTator, text mining | PubMed |
| A De Novo Frameshift Mutation in RPL5 with Classical Phenotype Abnormalities and Worsening Anemia Diagnosed in a Young Adult-A Case Report and Review of the Literature. | Medicina (Kaunas) | 2023 | 38004002 | PubTator, text mining | PubMed |
| Donor Cell Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: A Case Report and Literature Review. | Genes (Basel) | 2023 | 38003028 | PubTator, text mining | PubMed |
| Coexistence of ETV6-RUNX1 and MLL aberration among pediatric acute lymphoblastic leukemia: case reports and a literature review. | Transl Cancer Res | 2023 | 37969368 | PubTator, text mining | PubMed |
| Leukemia Cutis Presenting as a Morbilliform Eruption: A Case Report and Literature Review. | Cureus | 2023 | 37965423 | PubTator, text mining | PubMed |
| PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies-New Therapeutic Possibilities. | Cancers (Basel) | 2023 | 37958470 | PubTator, text mining | PubMed |
| Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L. | Cancers (Basel) | 2023 | 37958457 | PubTator, text mining | PubMed |
| Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia. | Front Pharmacol | 2023 | 37954840 | PubTator, text mining | PubMed |
| Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. | Signal Transduct Target Ther | 2023 | 37953273 | PubTator, text mining | PubMed |
| PRMT2 promotes HIV-1 latency by preventing nucleolar exit and phase separation of Tat into the Super Elongation Complex. | Nat Commun | 2023 | 37949879 | PubTator, text mining | PubMed |
| Congenital leukemia: A case report and review of literature. | World J Clin Cases | 2023 | 37946786 | PubTator, text mining | PubMed |
| A scoring system based on fusion genes to predict treatment outcomes of the non-acute promyelocytic leukemia pediatric acute myeloid leukemia. | Front Med (Lausanne) | 2023 | 37942413 | PubTator, text mining | PubMed |
| Molecular and clinical characterization of ANG expression in gliomas and its association with tumor-related immune response. | Front Med (Lausanne) | 2023 | 37928479 | PubTator, text mining | PubMed |
| Editorial: Individual and population-specific variation in cancer susceptibility, prevalence, and disease presentation. | Front Genet | 2023 | 37928240 | PubTator, text mining | PubMed |
| Small-molecule tools for YEATS domain proteins. | Curr Opin Chem Biol | 2023 | 37924571 | PubTator, text mining | PubMed |
| Ultrafine mapping of chromosome conformation at hundred basepair resolution reveals regulatory genome architecture. | Proc Natl Acad Sci U S A | 2023 | 37922325 | PubTator, text mining | PubMed |
| Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma. | Front Oncol | 2023 | 37916165 | PubTator, text mining | PubMed |
| Osteosarcoma Multi-Omics Landscape and Subtypes. | Cancers (Basel) | 2023 | 37894336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4300/papers?page=7